Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Annemans

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Clinical Drug Investigation|November 12, 2010
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent painLieven Annemans
Journal of Comparative Effectiveness Research|November 19, 2013
Maximizing health through the rapidly developing fields of comparative and cost-effectivenessLieven Annemans
Pharmacoeconomics|April 24, 2008
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision makingLieven Annemans
RMD Open|September 22, 2016
Costs of drugs for treatment of rheumatic diseasesRene Westhovens, Lieven Annemans
Nutrition (Burbank, Los Angeles County, Calif.)|February 23, 2018
The potential health and economic effects of plant-based food patterns in Belgium and the United KingdomJanne Schepers, Lieven Annemans
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Reflections on market access for personalized medicine: recommendations for EuropeKatherine Payne, Lieven Annemans
Expert Opinion on Pharmacotherapy|October 6, 2006
Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patientsKaren Moeremans, Lieven Annemans
Orphanet Journal of Rare Diseases|May 28, 2020
TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseasesLieven Annemans, Amr Makady
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disordersRaymond W Lam, Lieven Annemans
Cancer Treatment Reviews|May 27, 2006
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatmentLazzaro Repetto, Karen Moeremans, Lieven Annemans, et al.
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Clinical Drug Investigation|November 12, 2010
Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent painLieven Annemans
Journal of Comparative Effectiveness Research|November 19, 2013
Maximizing health through the rapidly developing fields of comparative and cost-effectivenessLieven Annemans
Pharmacoeconomics|April 24, 2008
Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision makingLieven Annemans
RMD Open|September 22, 2016
Costs of drugs for treatment of rheumatic diseasesRene Westhovens, Lieven Annemans
Nutrition (Burbank, Los Angeles County, Calif.)|February 23, 2018
The potential health and economic effects of plant-based food patterns in Belgium and the United KingdomJanne Schepers, Lieven Annemans
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Reflections on market access for personalized medicine: recommendations for EuropeKatherine Payne, Lieven Annemans
Expert Opinion on Pharmacotherapy|October 6, 2006
Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patientsKaren Moeremans, Lieven Annemans
Orphanet Journal of Rare Diseases|May 28, 2020
TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseasesLieven Annemans, Amr Makady
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disordersRaymond W Lam, Lieven Annemans
Cancer Treatment Reviews|May 27, 2006
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatmentLazzaro Repetto, Karen Moeremans, Lieven Annemans, et al.
Pageof 27